About Pyrroloquinoline
Pyrroloquinoline is an Agriculture company. It delivers enzyme solutions and probiotics for biopharmaceutical, fine chemicals, food, and cosmetics applications. It operates on a B2B model in Agriculture and Healthcare sectors. Its Indian entity Fido Pharma Private Limited reported revenue of ₹20.59 Cr. Pyrroloquinoline offers products and services including Enzymes, Probiotics, Probiotics Blends, and Nutraceuticals. Its focus areas include Food and Agriculture Tech, Food Additives, Probiotics and Probiotics Blends.
Company details
Fido Pharma Private Limited specializes in delivering enzyme solutions and probiotics for applications in biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. They focus on quality products like enzymes and probiotics blends, serving customer needs through innovative formulations. Based in Panchkula, India, the company supports various sectors with nutraceuticals and dietary supplements, emphasizing growth-promoting and anti-oxidative benefits without promotional claims.
- SectorsAgricultureHealthcare
- Email••••••••
- Phone•••• ••••
- Website pyrroloquinoline.com
- Legal Name Fido Pharma Private Limited
- Date of Incorporation 04 Mar, 2020
- Jurisdiction Panchkula, Haryana, India
- Indian entity revenue₹20.59 Cr
FY 2024 · +190% YoY
- Indian entity net profit₹4.07 Cr
FY 2024 · 20% margin
- Indian entity EBITDA₹4.89 Cr
FY 2024 · 24% margin
Associated legal entities of Pyrroloquinoline
Pyrroloquinoline operates through Fido Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fido Pharma Private Limited CIN U24230HR2020PTC085725 | Active | 04 Mar 2020 | Panchkula, Haryana | ₹20.6 Cr | 3 | View details |
Products & Services of Pyrroloquinoline
Pyrroloquinoline offers a comprehensive portfolio of products and services, including Enzymes, Probiotics, Probiotics Blends, and Nutraceuticals.
Enzyme solutions for redox processes in biopharmaceutical applications.
Probiotics for health and food industry growth promotion.
Blends of probiotics for stress tolerance and biochemical processes.
Nutraceuticals including PQQ for antioxidant and neuroprotective effects.
Board of directors of Fido Pharma Private Limited (Pyrroloquinoline)
Fido Pharma Private Limited is the primary company behind Pyrroloquinoline. The board of Fido Pharma Private Limited currently have 3 directors; the longest-serving is Tejal Ashok Vispute, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tejal Ashok Vispute DIN 08717158 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Parbhat Singh DIN 08717156 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Ritu Raj Singh DIN 10186291 | Director | 30 May 2023 | 3 yrs 4 mo | Fido Pharma Private Limited |
Financials of Pyrroloquinoline
Figures of Fido Pharma Private Limited, the primary company behind Pyrroloquinoline, for FY 2024. Revenue was ₹20.59 Cr (+190% year on year). Net profit was ₹4.07 Cr (20% margin). EBITDA was ₹4.89 Cr (24% margin). Revenue has grown at a compounded annual rate of +114% over three years.
- ₹20.59 CrRevenue · FY 2024 · +190% YoY
- ₹4.07 CrNet profit · 20% margin
- ₹4.89 CrEBITDA · 24% margin
- ₹50 LakhPaid-up capital
- +114%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Fido Pharma Private Limited are on its company page.
Detailed financial statements for Pyrroloquinoline
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pyrroloquinoline
The primary company behind Pyrroloquinoline, Fido Pharma Private Limited, reported revenue of ₹20.59 Cr for FY 2024, up 190% year on year.
Fido Pharma Private Limited specializes in delivering enzyme solutions and probiotics for applications in biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. They focus on quality products like enzymes and probiotics blends, serving customer needs through innovative formulations. Based in Panchkula, India, the company supports various sectors with nutraceuticals and dietary supplements, emphasizing growth-promoting and anti-oxidative benefits without promotional claims.
Pyrroloquinoline offers Enzymes, Probiotics, Probiotics Blends, and Nutraceuticals.
Pyrroloquinoline operates through Fido Pharma Private Limited.
The legal entities of Pyrroloquinoline currently have 3 directors, including Tejal Ashok Vispute, Parbhat Singh, Ritu Raj Singh.